Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACUTE-JIA: Infliximab vs DMARDs in Early Polyarticular JIA
NCT01015547Phase 3Completed
- Sponsor
- Helsinki University Hospital
- Start
- May 2003
- Primary completion
- Nov 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in juvenile idiopathic arthritis (JIA), sponsored by Helsinki University Hospital. Started May 2003; status: completed.
02
Drugs
infliximab
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT01015547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01015547.